77019-8

LOINC 2.82

Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing

NIP fet 18+21 aneu pnl Plas.cfDNA Seq

Definition

  • This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT panel, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 18 and 21 aneuploidies. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.

Component

  • Noninvasive prenatal fetal 18 & 21 aneuploidy panel

Specimen / system

  • Plas.cfDNA

Class

  • PANEL.MOLPATH

Property

  • -

Scale

  • -

Method

  • Sequencing

Related names

  • Genetics; Gyn; Gynecology; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Next generation sequencing; NGS; NIP fet 18+21 aneu pnl; OB; ObGyn; Obstetrics; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random

Index terms

  • Genetics
  • Gyn
  • Gynecology
  • Heredity
  • Heritable
  • high-throughput sequencing
  • HTS
  • Inherited
  • Molecular pathology
  • MOLPATH
  • Next generation sequencing
  • NGS
  • NIP fet 18+21 aneu pnl
  • Noninvasive prenatal fetal 18 & 21 aneuploidy panel
  • OB
  • ObGyn
  • Obstetrics
  • Pan
  • Panel.molpath
  • Panl
  • Pl
  • Plasma
  • Plsm
  • Pnl
  • Point in time
  • Random